Literature DB >> 5157780

The metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e) (1,4)diazepine (clozapine) in mice, dogs and human subjects.

R Gauch, W Michaelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5157780

Source DB:  PubMed          Journal:  Farmaco Prat        ISSN： 0430-0912


× No keyword cloud information.
  16 in total

1.  Bioanalytical assay of clozapine and its N-oxide metabolite and the determination of their blood levels in the dog.

Authors:  J Meier
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

2.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

3.  Multiple-dose pharmacokinetics of clozapine in patients.

Authors:  M G Choc; R G Lehr; F Hsuan; G Honigfeld; H T Smith; R Borison; J Volavka
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

4.  Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection.

Authors:  U Bondesson; L H Lindström
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Cytochrome P4502D6 genotype does not determine response to clozapine.

Authors:  M J Arranz; E Dawson; S Shaikh; P Sham; T Sharma; K Aitchison; M A Crocq; M Gill; R Kerwin; D A Collier
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

Review 6.  Clozapine plasma level monitoring: current status.

Authors:  T B Cooper
Journal:  Psychiatr Q       Date:  1996

7.  The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.

Authors:  D M Weiner; H Y Meltzer; I Veinbergs; E M Donohue; T A Spalding; T T Smith; N Mohell; S C Harvey; J Lameh; N Nash; K E Vanover; R Olsson; K Jayathilake; M Lee; A I Levey; U Hacksell; E S Burstein; R E Davis; M R Brann
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

Review 8.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

9.  Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.

Authors:  K I Melkersson; M-L Dahl
Journal:  Psychopharmacology (Berl)       Date:  2003-07-08       Impact factor: 4.530

10.  Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.

Authors:  G Schaber; I Stevens; H J Gaertner; K Dietz; U Breyer-Pfaff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.